HOB Biotech Group Corp.,Ltd (688656.SS)
CNY 102.72
(-1.37%)
CNY 102.72
(-1.37%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 394.4 Million CNY | 23.1% |
| 2022 | 320.39 Million CNY | 0.84% |
| 2021 | 317.7 Million CNY | 43.2% |
| 2020 | 221.85 Million CNY | -14.38% |
| 2019 | 259.12 Million CNY | 28.63% |
| 2018 | 201.44 Million CNY | 37.68% |
| 2017 | 146.31 Million CNY | 31.11% |
| 2016 | 111.6 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 101.79 Million CNY | -12.23% |
| 2024 Q2 | 115.97 Million CNY | 35.49% |
| 2024 Q1 | 85.59 Million CNY | -9.18% |
| 2023 Q3 | 109.62 Million CNY | -0.13% |
| 2023 FY | 394.4 Million CNY | 23.1% |
| 2023 Q4 | 94.25 Million CNY | -14.02% |
| 2023 Q2 | 109.75 Million CNY | 35.88% |
| 2023 Q1 | 80.77 Million CNY | 22.78% |
| 2022 FY | 320.39 Million CNY | 0.84% |
| 2022 Q3 | 103.32 Million CNY | 37.42% |
| 2022 Q2 | 75.18 Million CNY | -1.18% |
| 2022 Q1 | 76.08 Million CNY | -7.02% |
| 2022 Q4 | 65.79 Million CNY | -36.33% |
| 2021 FY | 317.7 Million CNY | 43.2% |
| 2021 Q4 | 81.83 Million CNY | -7.36% |
| 2021 Q3 | 88.33 Million CNY | 2.06% |
| 2021 Q2 | 86.55 Million CNY | 41.91% |
| 2021 Q1 | 60.99 Million CNY | -21.75% |
| 2020 FY | 221.85 Million CNY | -14.38% |
| 2020 Q4 | 77.94 Million CNY | 19.81% |
| 2020 Q3 | 65.05 Million CNY | 11.24% |
| 2020 Q1 | 20.36 Million CNY | -67.34% |
| 2020 Q2 | 58.48 Million CNY | 187.17% |
| 2019 FY | 259.12 Million CNY | 28.63% |
| 2019 Q4 | 62.36 Million CNY | -12.0% |
| 2019 Q3 | 70.86 Million CNY | -3.5% |
| 2019 Q2 | 73.43 Million CNY | 39.99% |
| 2019 Q1 | 52.46 Million CNY | 0.0% |
| 2018 FY | 201.44 Million CNY | 37.68% |
| 2017 FY | 146.31 Million CNY | 31.11% |
| 2016 FY | 111.6 Million CNY | 0.0% |